![pharma & biotech](https://www.peregrinevc.com/wp-content/uploads/2022/02/popup-pharma-biotech.png)
OticPharma started at Peregrine’s incubator as the developer of a foam-based medication for the treatment of ear disorders.
The company was merged into Tokai Pharmaceutical and later on changed its product strategy and its name to Eledon Pharmaceutical (NASDAQ: ELDN) , Exit through IPO.